Stock Track | Oscar Health Plummets 6.79% in Pre-market on Revenue Miss and House Subpoena

Stock Track
02/10

Oscar Health's stock plunged 6.79% in pre-market trading on Tuesday, following two significant negative developments that weighed on investor sentiment.

The health insurer reported fourth-quarter revenue of $2,805.235 million, which fell short of the Ibes estimate of $3,124 million. This revenue miss indicates weaker-than-expected financial performance for the quarter.

Additionally, Oscar Health was among eight Affordable Care Act health insurers subpoenaed by Republican House Judiciary Chair Jim Jordan as part of a widening investigation into potential fraud surrounding the use of premium subsidies. The regulatory scrutiny adds uncertainty and potential legal risks for the company.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10